Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Amphastar P

AMPH
Current price
40.9 USD +0.32 USD (+0.79%)
Last closed 40.78 USD
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 1 905 559 552 USD
Yield for 12 month -2.53 %
1Y
3Y
5Y
10Y
15Y
AMPH
21.11.2021 - 28.11.2021

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a nasal spray for the treatment of severe hypoglycemia; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, to prevent and treat deep vein thrombosis; REXTOVY and Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company provides Amphadase, an injection to absorb and disperse other injected drugs; Epinephrine injection for allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products; morphine injection for use with patient-controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures. In addition, it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges; Vasopressin to increase blood pressure; and Regadenoson, a stress agent for radionuclide myocardial perfusion imaging. Further, the company distributes recombinant human insulin APIs and porcine insulin API. Additionally, it develops generic product candidates, such as injectable, inhalation, and analytical technologies; biosimial product candidates; and intranasal epinephrine for the treatment of allergic reactions. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California. Address: 11570 6th Street, Rancho Cucamonga, CA, United States, 91730

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

68.5 USD

P/E ratio

15.2385

Dividend Yield

Current Year

+644 395 000 USD

Last Year

+498 987 000 USD

Current Quarter

+178 105 000 USD

Last Quarter

+180 556 000 USD

Current Year

+343 968 000 USD

Last Year

+248 860 000 USD

Current Quarter

+93 566 000 USD

Last Quarter

+108 403 000 USD

Key Figures AMPH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 237 722 000 USD
Operating Margin TTM 30.31 %
PE Ratio 15.2385
Return On Assets TTM 11.07 %
PEG Ratio 2.77
Return On Equity TTM 23.55 %
Wall Street Target Price 68.5 USD
Revenue TTM 644 395 008 USD
Book Value 13.3 USD
Revenue Per Share TTM 13.35 USD
Dividend Share
Quarterly Revenue Growth YOY 31.9 %
Dividend Yield
Gross Profit TTM 248 860 000 USD
Earnings Share 2.6 USD
Diluted Eps TTM 2.6 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY 5.5 %
Profit Margin 21.35 %

Dividend Analytics AMPH

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AMPH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation AMPH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 15.2385
Forward PE
Enterprise Value Revenue 3.5264
Price Sales TTM 2.9571
Enterprise Value EBITDA 9.4567
Price Book MRQ 2.9801

Financials AMPH

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AMPH

For 52 weeks

35.62 USD 67.66 USD
50 Day MA 47.48 USD
Shares Short Prior Month 3 595 530
200 Day MA 52.39 USD
Short Ratio 6.88
Shares Short 3 674 842
Short Percent 12.07 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

414.58 USD Microsoft Corporation +0.12 (+0.03%)
Detailed analytics

ETF funds


M

MDAXEX

208.70 CHF iShares MDAX UCITS ETF (DE) -11.84 (-4.92%)
Detailed analytics

Metals


Gold

2169.94 USD Gold -5.94 (-0.27%)
Detailed analytics